LT3564230T - Pakeistas guanidino junginys - Google Patents

Pakeistas guanidino junginys

Info

Publication number
LT3564230T
LT3564230T LTEPPCT/JP2017/046898T LT17886109T LT3564230T LT 3564230 T LT3564230 T LT 3564230T LT 17886109 T LT17886109 T LT 17886109T LT 3564230 T LT3564230 T LT 3564230T
Authority
LT
Lithuania
Prior art keywords
guanidine compound
substituted guanidine
substituted
compound
guanidine
Prior art date
Application number
LTEPPCT/JP2017/046898T
Other languages
English (en)
Inventor
Ken-Ichi Komori
Akishi Ninomiya
Shigeru Ushiyama
Masaru Shinohara
Koji Ito
Tetsuo Kawaguchi
Yasunori Tokunaga
Hiroyoshi Kawada
Haruka Yamada
Yusuke Shiraishi
Masahiro Kojima
Masaaki Ito
Tomio Kimura
Original Assignee
Ube Industries, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ube Industries, Ltd. filed Critical Ube Industries, Ltd.
Publication of LT3564230T publication Critical patent/LT3564230T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/107Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
LTEPPCT/JP2017/046898T 2016-12-28 2017-12-27 Pakeistas guanidino junginys LT3564230T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016255567 2016-12-28
PCT/JP2017/046898 WO2018124179A1 (ja) 2016-12-28 2017-12-27 置換グアニジン化合物

Publications (1)

Publication Number Publication Date
LT3564230T true LT3564230T (lt) 2022-04-11

Family

ID=62709416

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/JP2017/046898T LT3564230T (lt) 2016-12-28 2017-12-27 Pakeistas guanidino junginys

Country Status (21)

Country Link
US (2) US11396514B2 (lt)
EP (1) EP3564230B1 (lt)
JP (1) JP7103228B2 (lt)
KR (1) KR102607007B1 (lt)
CN (1) CN110114350B (lt)
AU (1) AU2017385291B2 (lt)
BR (1) BR112019012020A8 (lt)
CA (1) CA3048854A1 (lt)
CY (1) CY1125090T1 (lt)
DK (1) DK3564230T3 (lt)
ES (1) ES2909133T3 (lt)
HR (1) HRP20220383T1 (lt)
HU (1) HUE058181T2 (lt)
LT (1) LT3564230T (lt)
MX (1) MX2019007786A (lt)
PL (1) PL3564230T3 (lt)
PT (1) PT3564230T (lt)
RS (1) RS63103B1 (lt)
RU (1) RU2757279C2 (lt)
SI (1) SI3564230T1 (lt)
WO (1) WO2018124179A1 (lt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112789277B (zh) * 2018-10-22 2022-11-04 广东东阳光药业有限公司 胍类衍生物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2575411A1 (en) * 2004-07-27 2006-02-02 Astellas Pharma Inc. Thiazole derivatives having vap-1 inhibitory activity
TWI490214B (zh) 2008-05-30 2015-07-01 艾德克 上野股份有限公司 苯或噻吩衍生物及該等作為vap-1抑制劑之用途
US8293729B2 (en) 2009-06-24 2012-10-23 Boehringer Ingelheim International Gmbh Compounds, pharmaceutical composition and methods relating thereto
US8802679B2 (en) 2009-09-16 2014-08-12 Astellas Pharma Inc. Glycine compound
EA024102B1 (ru) * 2011-03-15 2016-08-31 Астеллас Фарма Инк. Гуанидиновые соединения, полезные для предотвращения и/или лечения диабетической нефропатии или диабетического отека желтого пятна
RU2733951C9 (ru) 2015-08-06 2020-12-22 Убе Индастриз, Лтд. Замещенные производные гуанидина

Also Published As

Publication number Publication date
KR20190097251A (ko) 2019-08-20
KR102607007B1 (ko) 2023-11-29
CN110114350B (zh) 2022-03-04
HUE058181T2 (hu) 2022-07-28
RU2019123574A (ru) 2021-01-29
US11814393B2 (en) 2023-11-14
RU2757279C2 (ru) 2021-10-12
AU2017385291A1 (en) 2019-07-18
CN110114350A (zh) 2019-08-09
ES2909133T3 (es) 2022-05-05
AU2017385291B2 (en) 2021-02-11
JP7103228B2 (ja) 2022-07-20
RU2019123574A3 (lt) 2021-03-25
BR112019012020A8 (pt) 2023-01-17
US11396514B2 (en) 2022-07-26
PT3564230T (pt) 2022-05-19
PL3564230T3 (pl) 2022-05-09
EP3564230B1 (en) 2022-02-09
DK3564230T3 (da) 2022-03-28
SI3564230T1 (sl) 2022-05-31
EP3564230A4 (en) 2020-06-03
CY1125090T1 (el) 2024-02-16
WO2018124179A1 (ja) 2018-07-05
MX2019007786A (es) 2019-08-16
HRP20220383T1 (hr) 2022-05-13
US20220315599A1 (en) 2022-10-06
BR112019012020A2 (pt) 2019-10-29
RS63103B1 (sr) 2022-04-29
EP3564230A1 (en) 2019-11-06
JPWO2018124179A1 (ja) 2019-10-31
US20190337962A1 (en) 2019-11-07
CA3048854A1 (en) 2018-07-05

Similar Documents

Publication Publication Date Title
HK1255921A1 (zh) 嘧啶化合物
GB2569389B (en) Compound
GB2569388B (en) Compound
HK1255832A1 (zh) 吡喃並二吡啶化合物
GB201721178D0 (en) Compound
GB201721179D0 (en) Compound
GB201521524D0 (en) Compound
GB201721180D0 (en) Compound
GB201721172D0 (en) Compound
GB201617103D0 (en) Compound
LT3630729T (lt) Pirimidino junginys
GB201612652D0 (en) Novel compound
LT3564230T (lt) Pakeistas guanidino junginys
PL3260289T3 (pl) Element kompozytowy
GB201709565D0 (en) Compound
GB201610497D0 (en) Compound
GB201518950D0 (en) Compound
IL268060B (en) Phenyldifluoromethyl-substituted prolinamide compound
HK1251574A1 (zh) 四氫噁庚英吡啶化合物
GB201721673D0 (en) Compound
GB201721324D0 (en) Compound
GB201703274D0 (en) Compound
GB201619526D0 (en) Compound
GB201619531D0 (en) Compound
GB201613035D0 (en) Compound